People prescribed GLP-1 agents liraglutide (Saxenda) or semaglutide for weight loss decreased their alcohol intake by almost ...

Many are from the most deprived areas, and a significant number are neurodivergent or have other health conditions, a study ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

Nutritional counseling remains a central component of obesity treatment, even in the era of highly effective weight-loss ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

Today, the Obesity Association™, a division of the American Diabetes Association®, (Obesity Association) announced the ...

Volume 17, Issue 4, on April 7, 2025, titled "Pharmacological recapitulation of the lean phenotype induced by the ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

The NHS has been urged to accelerate the rollout of weight loss drugs to “many millions” of people, as experts hailed the start of a “golden age” of anti-obesity treatments. A raft of studies ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...